Board of Radiation and Isotope Technology

The Board of Radiation and Isotope Technology, commonly known as BRIT, is a unit of India's Department of Atomic Energy focused on practical applications of radioisotopes and radiation technology. It operates within the national atomic-energy ecosystem and works with scientific, medical, industrial, and research institutions to support the use of nuclear technologies outside electricity generation. BRIT is headquartered in Navi Mumbai, where its pharmaceutical and laboratory activities are based at the BRIT/Bhabha Atomic Research Centre Vashi Complex. Its work is linked to the wider research capabilities of the Bhabha Atomic Research Centre (BARC), India's principal multidisciplinary nuclear research institution. BRIT also has connections with nuclear power facilities operated by Nuclear Power Corporation of India Limited (NPCIL), reflecting the relationship between India's research, production, and application infrastructure in the atomic-energy sector. The organization's remit centers on translating radioisotope and radiation science into usable products, services, and technologies. These applications include the preparation and supply of radioisotopes and radiopharmaceutical-related materials, the use of radiation in laboratories and industry, and the broader dissemination of radiation-based techniques. Its activities support India's medical, agricultural, industrial, and scientific capabilities, although the available reference material does not provide a complete current catalogue of BRIT's products or services. BRIT maintains six regional centres in Bengaluru, Delhi, Dibrugarh, Hyderabad, Kolkata, and Kota. The regional network gives the organization a national operational presence and supports the distribution, coordination, and adoption of radiation and isotope applications across India. Its institutional positioning is therefore different from that of a consumer-facing commercial brand: BRIT is a specialized public-sector technology and service organization whose credibility derives from its role within the Department of Atomic Energy and its links with national research and nuclear-power institutions. The organization is led by a Chief Executive. Shri Pradip Mukherjee has served in that position since 1 August 2019. No independently verified founding year, founder, ownership structure beyond its government affiliation, or current financial information is identified in the supplied reference material. BRIT should consequently be understood primarily as an active Indian government scientific-technology unit rather than as a separately listed company.

BRIT forms part of India's Department of Atomic Energy, the government system responsible for the country's nuclear science, nuclear power, and civilian atomic-technology programs. Its institutional purpose is to develop and promote applications of radioisotopes and radiation rather than to operate as a conventional consumer or industrial conglomerate. The organization's activities are connected to the research program of the Bhabha Atomic Research Centre. This relationship places BRIT within a model in which scientific research is converted into practical capabilities, products, and services for users beyond the core research establishment. BRIT is also associated with nuclear power plants operated by Nuclear Power Corporation of India Limited, linking its isotope and radiation work to the broader infrastructure of India's nuclear sector. Its principal facilities are located at the BRIT/BARC Vashi Complex in Navi Mumbai. The complex houses pharmaceutical and laboratory activities and serves as the organization's headquarters. BRIT's national reach is extended through regional centres in Bengaluru, Delhi, Dibrugarh, Hyderabad, Kolkata, and Kota. These centres provide a distributed institutional presence for radiation and isotope technology in India. The available reference material does not state a definitive founding year or identify an individual founder. It also does not provide a full chronology of major product introductions, reorganizations, or commercial milestones. BRIT is nevertheless described as an active Department of Atomic Energy unit with continuing responsibilities in radioisotope and radiation technology applications. Since 1 August 2019, Shri Pradip Mukherjee has served as BRIT's Chief Executive. The organization continues to be positioned as a government-supported technology and application body rather than a separately listed enterprise. Its work contributes to the use of nuclear science in civilian fields, including medical and laboratory activities, while its institutional relationships connect it to India's national research and nuclear-power programs.

• 2019

  Pradip Mukherjee becomes Chief Executive

  [1]Board of Radiation and Isotope Technologyen.wikipedia.org

  Pradip Mukherjee began serving as Chief Executive of BRIT on 1 August 2019.

A specialized Indian public-sector organization translating nuclear research and radioisotope capabilities into medical, industrial, scientific, and other civilian applications.

• Isotope technology

  Radioisotope applications

  BRIT's core remit includes the development and application of radioisotope technology. The organization operates within India's atomic-energy system and supports the practical use of isotopes in scientific, medical, industrial, and related civilian contexts. The supplied sources do not identify a complete product list or individual isotope catalogue.

• Medical and laboratory technology

  Radiopharmaceutical and laboratory activities

  BRIT maintains pharmaceutical and laboratory activities at the BRIT/BARC Vashi Complex in Navi Mumbai. These capabilities are associated with the preparation, handling, and application of radiation- and isotope-related materials. Specific named products, formulations, and current distribution details are not specified in the available reference material.

• Radiation technology

  Radiation technology applications

  The organization develops applications for radiation technology and supports its use beyond basic nuclear research. Its institutional scope covers technology and services relevant to research, medicine, industry, and other civilian fields, although the supplied sources do not enumerate particular programs or commercial offerings.

1. 1Board of Radiation and Isotope Technologyen.wikipedia.org
2. 2Board of Radiation and Isotope Technology official websitebritatom.gov.in